The intricate landscape of pharmaceutical synthesis relies heavily on precisely engineered chemical intermediates. These compounds, often possessing complex structures, are indispensable building blocks for novel therapeutic agents. Among these crucial molecules is N-(4-Amino-1-benzyl-3-hydroxy-5-phenyl-pentyl)-3-methyl-2-(2-oxo-tetrahydro-pyrimidin-1-yl)-butyramide 5-oxopyrrolidine-2-carboxylic acid (CAS 192726-06-0). Its unique chemical architecture makes it a valuable asset in the development of new pharmaceuticals, and understanding its role is key for R&D scientists and procurement managers.

The structure of N-(4-Amino-1-benzyl-3-hydroxy-5-phenyl-pentyl)-3-methyl-2-(2-oxo-tetrahydro-pyrimidin-1-yl)-butyramide 5-oxopyrrolidine-2-carboxylic acid offers multiple functional groups that can be strategically manipulated during synthesis. The presence of amino, hydroxyl, and amide functionalities, alongside aromatic rings, provides diverse reaction sites. This versatility allows chemists to incorporate it into complex molecular frameworks, aiming to achieve specific pharmacological properties. When you buy this pharmaceutical intermediate, you are investing in the potential for groundbreaking drug discovery.

For pharmaceutical companies, ensuring a consistent and high-quality supply of such intermediates is critical. Collaborating with a reputable manufacturer, particularly one located in a major chemical production hub like China, can provide access to bulk quantities at competitive prices. This ensures that research projects and eventual commercial production are not hindered by supply chain disruptions or inconsistent material quality. Sourcing from a trusted supplier like one offering CAS 192726-06-0 means gaining access to compounds with stringent purity standards, often exceeding 99%.

The journey from intermediate to finished drug product is long and rigorous. The purity and well-defined characteristics of the starting materials, such as N-(4-Amino-1-benzyl-3-hydroxy-5-phenyl-pentyl)-3-methyl-2-(2-oxo-tetrahydro-pyrimidin-1-yl)-butyramide 5-oxopyrrolidine-2-carboxylic acid, directly impact the success of subsequent synthetic steps and the safety and efficacy of the final pharmaceutical. Therefore, R&D scientists must be confident in the materials they purchase.

When evaluating suppliers for this complex molecule, consider their technical expertise, quality control measures, and ability to provide comprehensive documentation. Understanding the price structure, especially for bulk orders, is also a key aspect of procurement. The global market offers various options, but choosing a supplier with a proven track record in producing high-purity organic compounds is essential for any serious pharmaceutical development endeavor. Companies looking to buy this intermediate should inquire about its availability and explore wholesale prices.

In conclusion, N-(4-Amino-1-benzyl-3-hydroxy-5-phenyl-pentyl)-3-methyl-2-(2-oxo-tetrahydro-pyrimidin-1-yl)-butyramide 5-oxopyrrolidine-2-carboxylic acid is more than just a chemical; it is a critical enabler in the quest for new medicines. By partnering with reliable manufacturers and suppliers, pharmaceutical researchers can confidently access this essential intermediate, accelerating the development of life-saving treatments.